| Ytd | 29.13% | |
| 1y | 29.13% |
| Open | 30.59 | Prev Close | 30.65 | Low | 30.00 | High | 30.66 | Mkt Cap | 6.50B |
| Vol | 59.24K | Avg Vol | 1.28M | EPS | -0.05 | P/E | -670.68 | Forward P/E | 113.48 |
| Beta | 2.16 | Short Ratio | 2.07 | Inst. Own | 26.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 07-17 | Earning | 08-04 | 50-d Avg | 27.40 | 200-d Avg | 26.30 | 1yr Est | 30.64 |
The REIT market overvalues recent 'kinetic' earnings growth and undervalues 'potential' forward earn
Wells Fargo analyst John Kilichowski maintains Janus Living (NYSE:JAN) with a Overweight and rais
Barclays analyst Richard Hightower maintains Janus Living (NYSE:JAN) with a Overweight and raises
Real estate stocks with high RSI values may be overbought. OPI, VNO, and JAN are all showing high RS
During Wednesday's trading, 517 companies set new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Gainers AmeriServ Financial, Inc. (NASDAQ: ASRV) rose 199.3% to $12.30 in pre-market trading.